IAM
CL icon

Infusive Asset Management’s Colgate-Palmolive CL Stock Holding History

Infusive Asset Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.27M Sell
46,565
-1,251
-3% -$109K 1.94% 19
2026
Q1 		$4.08M Sell
47,816
-10,681
-18% -$952K 1.97% 22
2025
Q4 		$4.62M Sell
58,497
-891
-2% -$69.9K 1.97% 23
2025
Q3 		$4.75M Sell
59,388
-1,321
-2% -$113K 2.18% 19
2025
Q2 		$5.52M Sell
60,709
-1,256
-2% -$115K 2.46% 15
2025
Q1 		$5.81M Sell
61,965
-15,650
-20% -$1.4M 2.69% 14
2024
Q4 		$7.06M Buy
77,615
+68,429
+745% +$6.53M 3.14% 14
2024
Q3 		$954K Hold
9,186
– – 0.4% 37
2024
Q2 		$891K Buy
+9,186
New +$847K 0.36% 33
2022
Q2 		– Sell
-2,535
Closed -$192K – 17
2022
Q1 		$192K Sell
2,535
-610
-19% -$48.3K 0.09% 24
2021
Q4 		$268K Sell
3,145
-215
-6% -$16.8K 0.09% 31
2021
Q3 		$254K Sell
3,360
-125
-4% -$9.93K 0.05% 34
2021
Q2 		$284K Sell
3,485
-416
-11% -$34K 0.06% 42
2021
Q1 		$308K Buy
3,901
+468
+14% +$36.7K 0.07% 33
2020
Q4 		$294K Buy
+3,433
New +$284K 0.1% 30

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Infusive Asset Management's CL Position: Q2 2026 in Review

Infusive Asset Management reduced its Colgate-Palmolive (CL) stake by 2.6% in Q2 2026, selling an estimated $109K and leaving 46,565 shares worth $4.27M. The position accounts for 1.94% of the portfolio, ranked #19.

Infusive Asset Management first reported a position in CL in Q4 2020 and has held it in 15 quarters since. The position peaked at $7.06M in Q4 2024. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Infusive Asset Management held 46,565 shares of Colgate-Palmolive worth $4.27M as of Q2 2026.
  • Infusive Asset Management sold 1,251 Colgate-Palmolive shares in Q2 2026, an estimated $109K.
  • Colgate-Palmolive made up 1.94% of Infusive Asset Management's portfolio in Q2 2026, its #19 holding.
  • Infusive Asset Management first reported a position in Colgate-Palmolive in Q4 2020 and has held it in 15 quarters since.
  • Infusive Asset Management's Colgate-Palmolive position peaked at $7.06M in Q4 2024.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Infusive Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.